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Abstract 
In the field of regenerative medicine, stem cells are highly promising due to their innate ability to generate multiple 
types of cells that could replace/repair damaged parts of human organs and tissues. It has been reported that both 
in vitro and in vivo function/survival of stem cells could significantly be improved by utilizing functional materials 
such as biodegradable polymers, metal composites, nanopatterns and nanohybrid particles. Of various biocompatible 
materials available for use in stem cell‑based therapy and research, carbon‑based materials—including fullerenes gra‑
phene/graphene oxide and carbon nanotubes—have been found to possess unique physicochemical characteristics 
that contribute to the effective guidance of stem cell differentiation into specific lineages. In this review, we discuss a 
number of previous reports that investigated the use of carbon‑based materials to control stem cell behavior, with a 
particular focus on their immense potential to guide the osteogenesis of mesenchymal stem cells (MSCs). We hope 
that this review will provide information on the full potential of using various carbon‑based materials in stem cell‑
mediated regenerative therapy, particularly for bone regeneration and repair.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
1 Introduction
Regenerative medicine seeks to find effective methods 
or tools to treat damaged tissue and organs by restor-
ing their structure and function. Numerous approaches 
have been proven useful to regenerate damaged parts of 
the human body, such as insertion of cell-friendly bioma-
terials [1, 2], injection of growth factors/chemicals [3], 
autologous tissue engraftments, and stem cell treatments 
[4]. Of these, stem cell-mediated tissue repair is one of 
the most promising areas, and has received an extensive 
amount of attention for more than a decade [5].
Stem cells encompass all cells capable of generating 
multiple types of cells through differentiation, and they 
are known to be useful resources to develop regenera-
tive therapies [6–9]. Stem cells are generally categorized 
into cells with pluripotency (e.g., embryonic stem cells, 
induced pluripotent stem cells), and cells with multipo-
tency (e.g., mesenchymal, hematopoietic, neural stem 
cells) [10]. Despite the limited capability for differentia-
tion of multipotent stem cells compared to that of pluri-
potent stem cells, multipotent cells are still considered to 
be promising candidates for use in regenerative therapies 
since they are easy to obtain without encountering ethi-
cal issues and, most importantly, are relatively free from 
teratoma formation/tumor development [11].
Mesenchymal stem cells (MSCs) are a type of multi-
potent stem cells that can be obtained from bone mar-
row, adipose tissue and even from dental tissue. MSCs 
are capable of generating a variety of cells, including 
chondrocytes (cartilage), osteocytes (bone), myocytes 
(muscle), adipocytes (fat) and neuronal cells [12]. Hence, 
it is obvious that the differentiation of MSCs should be 
controlled with precision to achieve certain types of cells 
prior to transplantation in order to exploit the potential 
of MSC-based therapies to its fullest. To this end, the 
most common method to induce the differentiation of 
MSCs is the treatment with medium containing multiple 
growth factors, proteins, and chemicals that have been 
proven to be highly effective in guiding MSC differen-
tiation toward specific lineages. Specifically, factors for 
osteogenic differentiation, such as bone morphogenetic 
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protein (BMP), basic fibroblasts, dexamethasone, vitamin 
D3, beta glycerophosphate, and ascorbic acid have been 
reported to convert MSCs into osteoblasts with high effi-
cacy [13].
While traditional materials/molecules, known as ‘solu-
ble cues’ continue to show its effectiveness in MSC dif-
ferentiation, other ‘insoluble cues’ have been reported to 
successfully regulate physical/mechanical properties of 
substrates in which cells attach, grow, and differentiate 
[14]. Micropatterns, nanopatterns, nanoparticles and bio-
hybrid materials have been widely used as physicochemi-
cal factors in conjunction with proper functionalities on 
material surfaces in order to (i) maintain multipotency 
of the MSCs for long-term culture [15], (ii) control cell 
adhesion, migration and proliferation [16, 17], and (iii) 
guide their differentiation into specific lineages [1, 18, 
19]. Among various materials available for stem cell stud-
ies, carbon-based materials, including fullerenes, carbon 
nanotubes (CNTs), and graphene/graphene oxide (GO) 
have shown immense potential for cell-friendly and cell-
adhesive materials with lower toxicity [20, 21]. Remark-
ably, these carbon-based materials have demonstrated 
their excellent capabilities in stem cell differentiation into 
specific lineages, especially for bone (osteogenic) differ-
entiation. This could be attributed to their unique surface 
properties, such as absorption/repulsion of specific dif-
ferentiation factors, and improvement in cell adhesion 
via the interaction between the cell membrane and the 
surface of the carbon materials [22, 23].
Despite the physicochemical and mechanical charac-
teristics of carbon-based materials to induce stem cell 
differentiation into specific lineages, there have been no 
reviews to date which explore specific application of car-
bon-based materials in osteogenic differentiation. To this 
end, this review will highlight and discuss various strat-
egies in biomedical application of carbon-based materi-
als, with a particular focus on their usage in osteogenic 
differentiation of MSCs, obtained from various tissues. 
In this study, carbon-based materials are categorized 
into three different groups: (i) fullerenes (zero dimen-
sional material), (ii) graphene and GO (two dimensional 
material), and (iii) carbon nanotubes (three dimensional 
material). Thereafter, their mechanism of action (e.g., cell 
patterning, adhesion control, molecule absorption) and 
potential applications in the osteogenic differentiation of 
MSCs will be extensively discussed (Fig. 1).
2  Guiding osteogenic differentiation of MSCs 
using pure carbon‑based materials
2.1  Fullerenes
Fullerenes, first designed by Kroto et al. [24], are molecules, 
consisted of carbon atoms (C60), that can be shaped into 
hollow spheres, spheroids, and numerous other forms. 
Their hollow shape is analogous to clathrin-coated vesicles 
in cells which allows fullerenes to be used as drug deliv-
ery vehicles or nano-sized gene-carriers. However, fuller-
ene is also known to have high reactivity, attributed to its 
high angle strain, which could result in several detrimen-
tal effects on cells, such as denaturation of DNA or plasma 
membrane damage. Nonetheless, fullerenes could be 
employed to target tumor cells or antigens that are known 
to show resistance to certain medicine. Subsequently, the 
following section will explore the viability of fullerenes in 
biomedical application and regenerative medicine.
The first paper, describing the use of fullerenes in 
osteogenesis, was published by Bacakova et  al. in 2007 
[21]. The study initially explored the possibility of apply-
ing various types of carbon materials, such as fullerenes, 
carbon nanotubes, diamond layers, and carbon nano-
materials to bone tissue regeneration. Later on, the same 
research group also successfully synthesized fullerene lay-
ers, coated with carbon fiber-reinforced carbon compos-
ites (CFRC), and cultured MG 63 cells on a terpolymer 
of poly-tetrafluoroethylene. The nano-patterns, engraved 
on the CFRC surface, reportedly assimilated the extracel-
lular environment that envelops the natural bone tissue, 
and consequently improved the adhesion and differen-
tiation of bone-derived cells. The paper comprehensively 
suggested the possibility of exploiting fullerene layers for 
bone tissue regeneration of respective osteogenic cells.
On the other hand, Kopova et al. [25] also reported the 
effect of fullerenes on human bone-derived cells by using 
fresh (1 week old) and aged (1 year old) fullerene films.
Kopova et  al. used immunofluorescence staining on 
the two fullerene films to determine the amount of DNA 
damage on genes that control the growth of human bone 
tissue (Fig. 2). The staining results showed that cells cul-
tured on fresh fullerene films showed a low level of activ-
ity similar to that of the control cells cultured on pure 
glass. However, the cell activity on the aged fullerene 
films was reported to be higher than that of cells grown 
on the fresh films. Therefore, it was concluded that the 
aged films offer more possibilities in culturing cells.
In 2014, Yang et al. [26] reported on the use of support-
ing materials for osteogenesis of human adipose-derived 
stem cells (hADSCs). The authors utilized antioxidant, 
hydroxylated fullerene (fullerol), and FoxO1 (transcrip-
tion factor) to reduce cellular reactive oxygen species 
(ROS) activities, and induce osteoblast differentiation. 
Their results indicated minimal damage of human ADSCs 
by fullerene. Moreover, they found that nano-fullerols in 
fact increased human ADSC osteogenesis by procreating 
a low intracellular ROS level for the cells during the bone 
formation. Lastly, they also suggested a mechanism to 
regulate osteoblast differentiation of MSCs by elevating 
FoxO1 and reducing the ROS.
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Likewise, Kopova et al. [27] reported on two different 
types of fullerene/Ti films and their effects on the growth 
and potential damage of human bone cells. Kopova and 
his team successfully synthesized composites, infused 
with a micro-patterned complex by mixing fullerene 
and titanium. They compared the MG-63 cell activities 
on between pure fullerene films and C60/Ti films. It was 
revealed that the fullerene combined with titanium films, 
fresh films, and aged films showed no ostensive differ-
ences on cell growth, such as their metabolic activity or 
viability. Moreover, it was also deduced that there were 
no confirmed signs of DNA damage when cultivating 
cells on mixed films.
It could be conclusively postulated that fullerenes offer 
multitudinous possibilities in regenerative medicine and 
tissue engineering. Despite initial complications with 
cytotoxicity and its tendency to induce DNA damage, 
fullerenes could be minimized by either incorporating 
with other substances (titanium), or modifying its surface 
with chemicals. Moreover, its unique surface property 
that closely assimilates the bone tissue matrix environ-
ment would serve as a great unparalleled asset in future 
tissue engineering applications.
2.2  Graphene and graphene oxide
While chitosan, poly-l-lactic acid (PLLA), and poly-
caprolactone (PCL) have been widely used for bone 
regeneration, challenges still remain in assimilating their 
mechanical and chemical properties to those of the natu-
ral bone tissue [28]. In addition, some polymers require 
chemical modifications, owing to their lack of sites for 
cell adhesion and frequent immune responses, triggered 
by their byproducts [29]. However, graphene and its 
derivatives [graphene oxide (GO), and reduced graphene 
oxide (rGO)] have all shown to induce and sustain stem 
cell growth and differentiation with considerable effi-
cacy, while being capable of enhancing osteogenic dif-
ferentiation [22]. Thus, graphene and its derivatives have 
emerged as the next promising material in bone regen-
eration and tissue engineering.
First, graphene is an allotrope of carbon molecules that 
comes in shapes of two-dimensional, atomic-scale, honey-
comb lattice. It has several novel properties, including 
excellent mechanical strength, and high thermal and 
electrical conductivity, making it an apropos candidate 
for electro-convulsive therapy. Consequently, graphene 
has been used in electrical, electrochemical, and optical 
applications [30, 31] as a newly applicable material for 
stem cell applications, such as osteogenesis. It is com-
monly obtained via chemical vapor deposition (CVD), 
which is often used in high-quality and high-quantity 
production prior to transfer into various substrates [32]. 
Considering the fact that graphene is non-cytotoxic and 
allows mesenchymal stem cells to attach and proliferate 
Fig. 1 Schematic diagram depicting the guidance of osteogenesis for mesenchymal stem cells using carbon‑based nanomaterials
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[33, 34], it has become an increasingly promising sub-
strate for anchorage-dependent cells, i.e., mesenchymal 
stem cells (MSCs) since anchorage-dependent cells must 
adhere to substrates in order to spread, proliferate, and 
function properly [20, 35]. However, carbon-based mate-
rials exhibit different effects on cells when administered 
Fig. 2 A Concentration of vinculin (a), talin (b), osteocalcin (c) and ICAM‑1 (d) in osteoblast‑like MG 63 cells on day 8 after seeding on the pure 
terpolymer of polytetrafluoroethylene, polyvinyldifluoride and polypropylene (Ter), terpolymer mixed with 4 wt% of single‑wall carbon nanohorns 
(SWNH) or 4 wt% of high crystalline electric arc multi‑wall carbon nanotubes (MWNT‑A) and tissue culture polystyrene (TCPS). B Immunofluores‑
cence staining of markers of DNA damage response: 53BP1 (green) and gamma‑H2AX (red) in human osteoblast‑like U‑2 OS cells on micropatterned 
or continuous fresh and aged fullerene films after 7 days of cultivation. GS, microscopic glass coverslips, reference material; GS + NCS, positive 
control to DNA damage response, induced by 1 h incubation of U‑2 OS cells in neocarzinostain (NCS; 700 ng/mL). Fullerol pre‑treatment increased 
osteogenic potential of human aDscs. Cells were pretreated with fullerol (1.0 or 0.1 µM) for 7 days, followed by osteogenic induction for 14 days 
(n = 4). C Gene expression of osteogenic markers, Runx2, OCN, and ALP by real‑time rT‑Pcr at day 7, using 18 s as internal control. D Alizarin red 
staining at day 21. Letters a and b denote p = 0.05 versus BM and gP/DeX group, respectively. A The reprint of this figure from [21] is permitted by 
the Elsevier. B The reprint of this figure from [25] is permitted by MDPI C, D The re‑print of this figure from [26] is permitted by Dove Medical Press
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in  vivo since they present various bio-distribution pat-
terns [36, 37]. In that sense, graphene can be functional-
ized to develop bioactivity of the composite, or to be used 
as a surface coating on biomaterial substrates. This arises 
from the surface chemistry of biomaterials which serve as 
a potential tool to control biological responses [38] while 
cell adhesion, viability, and proliferation determine the 
biocompatibility of the substrate [20, 32, 35–39].
Several studies have found that graphene has an abil-
ity to capture stem cells [40] and control osteogenic dif-
ferentiation of human mesenchymal stem cells (hMSC) 
[41]. Nayak et al. [42] found that graphene induces osteo-
genesis when cultured without BMP-2 (common growth 
factor for bone generation). The authors used four dif-
ferent substrates (polydimethylsiloxane (PDMS), PET, 
glass slide and Si/SiO2) with varying stiffness and surface 
roughness to investigate the effect of graphene on stem 
cell growth. As shown in Fig. 3C, D, when cultured with-
out BMP-2, all four substrates with graphene showed a 
higher quantity of alizarin red compared to substrates 
without graphene. In addition, even after being cultured 
with BMP-2, the groups with graphene showed a higher 
concentration of alizarin red. This proved that graphene 
not only shows a tendency for osteogenesis of hMSCs, 
but also a synergetic effect when used with BMP-2 for 
bone tissue generation.
Moreover, Lee et  al. [13] reported that the binding 
ability of graphene accelerates the differentiation of 
MSCs toward the osteogenic lineage. They conducted an 
experiment in which they cultured MSCs on graphene 
made via CVD. During the culture process, they intro-
duced certain chemicals, such as insulin, dexamethasone, 
β-glycerolphosphate, and ascorbic acid. As illustrated in 
Fig.  3E, F, graphene has a tendency to pre-concentrate 
osteogenic inducers which consequently enhance the 
osteogenic differentiation of hMSCs. While prior stud-
ies have shown that it took 21 days to complete chemi-
cally-induced osteogenic differentiation [43], Lee’s study 
showed that it only took 12 days using graphene.
GO is a form of graphene that includes numerous oxy-
gen atoms. Its oxygen composition gives rise to various 
functional groups in GO, such as epoxide, carboxyl, and 
hydroxyl groups [44]. These functional groups provide 
GO a greater mechanical strength, and allow it to inter-
act with polymers more actively than non-functionalized 
graphene [13]. Rameshwar et al. showed synergetic effect 
of GO with an osteoinductive material [45]. Rameshwar’s 
team used calcium phosphates (CaP) as a biomaterial 
for their osteoconductivity and osteoinductivity. They 
synthesized GO-CaP nanocomposites and introduced 
them to hMSCs in osteogenic medium. The results from 
immunofluorescence staining of the osteoblast mark-
ers showed that the osteogenesis process was successful 
in the consecutive order of GO-CaP, CaP, GO, and con-
trol. Their research conclusively showed that GO-CaP 
nanocomposites not only facilitated the osteogenesis of 
hMSCs, but also enhanced calcium deposition by the 
osteoblasts. Hence, we conclude that graphene and GO 
both enhance and control the osteogenic differentiation 
of hMSCs.
2.3  Carbon nanotubes
Carbon nanotubes (CNTs) are another type of carbon-
based nanomaterials that are known to support the 
attachment, and growth of adult stem cells and progeni-
tor cells, including osteoblasts and myoblasts [46, 47]. 
They are composed of rolled up nano-sized graphene 
sheets with a helical structure and π electron conjuga-
tion which provide elasticity, high chemical stability, and 
electrical conductivity [48, 49]. CNTs’ unique proper-
ties attribute to its versatility to be used in various areas, 
including nanotechnology, material science, and elec-
tronics. In recent studies, CNT-based materials were 
found to have considerable potentials for their use in 
numerous cellular applications, including cancer therapy 
[50] and tissue engineering [51]. Subsequently, their abil-
ity to support cell adhesion, cell growth, and differentia-
tion has been considered for use with various stem cell 
lines, including hMSCs, neural stem cells, and embryonic 
stem cells [52–55].
CNTs are generally classified into single-walled CNT 
(swCNT), multi-walled CNT (mwCNT), and functional-
ized CNT, all of which can be easily adjusted to increase 
their biocompatibility as a cellular culture substrate. It is 
reported that swCNTs can promote the differentiation 
of hMSCs without the need for differentiation-inducing 
media [56]. Few studies have shown that hMSCs formed 
focal adhesions and grew in a considerable rate on sin-
gle-walled CNTs (swCNTs) [46, 54]. Moreover, swCNTs 
treated with oxygen plasma have shown synergetic effects 
on differentiation and adhesion of the hMSCs [56]. The 
stress from stretching stem cells on microscale molecular 
patterns generates tension on the actin filaments, which 
in return enhances osteogenesis [57].
Baik et  al. [56] conducted an experiment where each 
of pure swCNTs and oxygen-plasma treated swCNT 
(O-swCNT) monolayers on a glass surface (Fig.  4B,C) 
were used as substrates with glass as control (Fig.  4A). 
The MSCs for osteogenic differentiation were seeded 
onto the substrates, and the cell adhesion process was 
analyzed by staining the actin fibers which indicated the 
average area per cell. Cell adhesion and proliferation of 
hMSCs were visualized by culturing hMSCs on each of 
the substrates (Figs. 4D-I, 5).
Zhang et  al. [58] reported that the nanoscale surface 
roughness of swCNTs affects the deformation of the cell 
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membrane and impacts distribution and diffusion of 
membrane proteins, including the focal adhesion proteins 
that are crucial in cell adhesion. It was concluded that the 
effect of swCNTs on adhesion proteins promotes hMSCs 
and osteoblast-like-cells to grow better on swCNT films 
than on glass substrates. It was also reported that CNTs 
encompass the ability to improve the absorption of 
extracellular matrix (ECM) proteins, i.e. fibronectin (FN), 
laminin, and vitronectin [59]. FN-CNT hybrid nanostruc-
tures have shown to improve either the cell adhesion or 
cell growth more efficiently than glass substrates (Fig. 5). 
For instance, FN-coated swCNTs were shown to improve 
the spreading of hMSCs more efficiently than common 
tissue culture plates [54], while improvement in induction 
Fig. 3 A Shape of graphene, B shape of graphene oxide. C Cells grown in the absence of BMP‑2. Control with coverslips is shown as a reference. 
D Cells grown in the presence of BMP‑2. Conventional plain coverslips were used as a positive control. E Osteogenic differentiation visualized by 
Alizarin Red staining after 12 days of incubation, on PDMS (i) with induction and (ii) without induction, on G (iii) with induction and (iv) without 
induction, and on GO (v) with induction (vi) and without induction. Scale bars are 200 μm. F The quantification demonstrated a significantly higher 
amount of Alizarin Red staining in the MSCs differentiated on G (*p < 0.05; n = 4 for each group) (A, B) The reprint of this figure from [22] is permit‑
ted by the Hindawi Publishing Corporation (C, D) The reprint of this figure from [42] is permitted by the American Chemical Society. (E, F) The reprint 
of this figure from [13] is permitted by the American Chemical Society
Page 7 of 14Kang et al. Nano Convergence  (2017) 4:2 
of osteogenesis of hMSC was also observed using msC-
NTs. However, the same degree of improvement was not 
observed with the use of graphite due to the diversity in 
topography, and the proteins secreted from the cultured 
cells [60, 61]. It was concluded that the topography of 
CNTs exerts significant effects on cell spreading, mor-
phology and different stem cell lineages [19, 62–65].
On the other hand, square-patterned and ranged CNTs 
can also be used to increase the expression of particu-
lar osteogenic genes, such as osteocalcin and alkaline 
phosphatase [56]. The modified topography of CNTs 
enhanced both cell proliferation and osteogenic differen-
tiation of hMSCs while the alignment of CNTs improved 
the expression of the osteoblast gene [66], and the hMSC 
media was dispersed more easily by functionalized CNTs 
(Fig. 6).
Despite numerous advantages that CNTs present, 
several cases of in  vivo toxicity have been reported. 
The most noticeable toxicity arises from DNA destruc-
tion in mouse embryonic stem cells (mESCs), due to 
the increased oxidative stress. Consequently, the rise in 
oxidative stress generates free radicals, which leads to 
increased peroxidative condition [67, 68]. Although it 
was shown that COOH- functionalized CNTs have less 
in  vivo cytotoxicity [31], CNTs are hardly used seper-
ately for medical purposes without modification of their 
Fig. 4 hMSCs growth on swCNT monolayers. A Glass substrate was used as a control. B swCNTs were adsorbed onto the glass substrate to form 
a swCNT monolayer. C Oxygen plasma treatment was applied to modulate the swCNT surface properties. Adhesion and proliferation of hMSCs on 
various substrates. Fluorescence images of actin filaments show the morphology of hMSCs on D a glass substrate, E a swCNT monolayer, and F an 
oxygen‑plasma‑treated swCNT monolayer (O‑swCNT). Scale bars are 100 μm. The quantitative analysis was visualized with g the averaged value of 
area per cell (number of cells, n = 200), H the averaged value of the ratio of long and short axial lengths (a/b in b; n = 200), and I the averaged MTS 
assay value at day 6 (n = 3). In all analyses, Student’s t test was utilized to calculate the significance (*p < 0.05). Reprinted with permission from [14]. 
The reprint of this figure from [56] is permitted by WILEY–VCH Verlag GmbH & Co
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surface properties. There had been efforts to increase the 
activity and interaction of CNTs through surface modifi-
cation [69], however the toxicity of CNTs remains to be a 
persistent problem in biomedical application.
Therefore, CNTs are considered to be a promising bio-
medical material with multitudinous potentials as they 
can serve as representatives of microenvironment and 
nanotopography. Despite several complications con-
cerning oxidative cytotoxicity, CNTs will continue to be 
explored for its application in biomedical engineering 
and tissue therapies.
3  Guiding osteogenic differentiation of MSCs 
using modified carbon‑based materials
3.1  Nano/micro patterns of carbon nanomaterials
It is commonly known that changes in the microenviron-
ment induce dynamic differentiation of hMSCs. While 
nano/micro patterns have been reported to be highly 
effective in modulating stem cell differentiation by regu-
lating the cell affinity and extension, carbon-derived pat-
terns are also capable of upregulating the differentiation 
of hMSCs. In that sense, patterned graphene was tested 
for its capacity to differentiate hMSCs in comparison to 
efficacy of graphene in differentiation of hMSCs.
Kim et  al. [70] reported that nano-sized Graphene 
Oxide (NGO) patterns, with a size approximately 
of 100  nm, enhanced the elongation of hMSCs, and 
resulted in a considerable increase in osteogenesis of 
hMSCs in comparison to common culture plates and 
polydimethylsiloxane (PDMS). Moreover, a graphene 
nanogrid, constructed from graphene nanoribbons 
(GONRs), which are elongated strips of graphene, was 
also reported to enhance adhesion and differentiation 
of hMSCs even without differentiation factors [71]. 
Similarly, Akhavan et  al. [34] reported that the rate of 
proliferation of the MSCs on the nanogrid was higher 
than that of non-regulated proliferation on PDMS and 
GO sheets. Therefore, it could be concluded that the 
rGONR attributed to the absorption rate of differentia-
tion chemicals, as well as the surface topography of the 
patterns.
In addition, similar acceleration in cellular activities 
was also observed on CNTs with engraved nanopatterns. 
First, aligned CNTs showed a higher rate of proliferation 
and differentiation for the hMSCs than the CNTs that 
are randomly oriented as seen in Fig.  7 [78]. Namgung 
et al. [47] cultured hMSCs on the aligned CNT network 
as well as on the randomly oriented network to investi-
gate whether the arrangement of CNTs would affect the 
transduction mechanism of hMSCs. Their results showed 
that the transduction mechanism, promoted by the high 
tension in the elongated hMSCs on the oriented CNTs, 
indeed promoted both proliferation and osteogenesis 
of hMSCs. Park et  al. discovered that CNT/Nanow-
ire (CNT/NW) monolayer patterns could also play an 
important role in controlling stem cell adhesion and mor-
phology. Generally, MSC shows higher affinity to CNT 
patterns than the NW coating. This could be exploited 
to produce high density swCNT patterns on electrodes, 
allowing MSCs to grow on the swCNT patterns with sub-
stantial efficiency.
MSC differentiation is often influenced by the 
nanoscale diversity of swCNTs, including thickness, 
roughness and surface characteristics [72]. Lee et  al. 
reported the thickness of their swCNTs to be about 
95  nm with a roughness of 9.81  nm which reportedly 
accelerated the rat MSCs (rMSCs) growth. On the other 
hand, Bitirim et  al. [73] informed that MSCs showed 
similar attachment tendencies to both collagen-coated 
swCNT plates, and those without collagen coating. How-
ever, the collagen-coated CNTs had a stronger adhe-
sion of MSCs, which implies the importance of surface 
properties in the adhesion of MSCs. In addition, a case 
was reported where linear CNT patterns were able to 
Fig. 5 Selective growth of hMSCs on FN‑CNT nanostructures. A On 
the glass substrates, the phase‑contrast image of hMSCs on line pat‑
terns of FN‑CNT structures without swCNTs. B Immunostained by vin‑
culins (green) of the hMSCs. Vinculins are the full of edge of FN‑CNT 
structure. C Fluorescence image of actin (red) and vinculins (green) of 
the hMSCs. Also grown on bare‑glass. Arrows are focal‑adhesion sites. 
D Average result of the cell area on bare glass, CNT, FN coated bare 
glass, swCNT‑coated glass treated FNs. The reprint of this figure from 
[59] is permitted by WILEY–VCH Verlag GmbH & Co
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control the morphology of hMSCs to differentiate into 
neural cells [74], which suggests that the pattern of car-
bon-derived material is excellent for the osteogenic dif-
ferentiation of MSCs.
Therefore, it could be concluded that controlling the 
differentiation of hMSCs on the carbon material patterns 
offers multitudinous opportunities, especially in osteo-
genic differentiation and neural differentiation. However, 
further studies on both properties of carbon patterns and 
hMSCs are still necessary in order to overcome the cyto-
toxicity problem of CNTs. Nonetheless, the carbon mate-
rial patterns show abounding potentials in regenerative 
engineering, as well as in biomedical and tissue therapies.
3.2  Hybrid carbon nanomaterials
Graphene is known to have unique physicochemical 
properties which allows it to be considered for numerous 
integrative applications when utilized with other poly-
mers. Numerous studies have investigated the viability 
of graphene-based hybrid nanomaterials, such as gra-
phene polymer nanoparticles, nanoparticle-decorated 
graphene sheets, graphene-embedded nanoparticles, 
and graphene-encapsulated nanoparticles in assisting the 
cellular activity of various types of stem cells, including 
embryonic stem cells (ESCs), induced pluripotent stem 
cells (iPSCs), mesenchymal stem cells (MSCs), and neural 
stem cells (NSCs) [75, 76]. For instance, Solanki et al. [77] 
Fig. 6 Osteogenic differentiation of hMSCs on two forms of CNT platform (A, B). Immunofluorescence images of osteocalcins (OCNs, green) and 
osteopontin (OPN, green) respectively, in hMSCs. The actin of hMSCs was stained with TRITC‑phalloidins (red). C Expression levels of osteogenic 
genes, such as OCN, OPN, alkaline phosphatase (ALP), and core binding factor or alpha1 (CBFA1). D Expression levels of genes included transduc‑
tion pathways such as focal adhesion kinase (FAK), Rho family of GTPases member A (RhoA), and Rho‑associated coiled‑coil protein kinas (ROCK). 
E Expression level of the genes of Wnt‑antagonists, such as dikkopf‑1 (DKK1) and secreted frizzled‑related protein type 3 (sFRP3). The reprint of this 
figure from [66] is permitted by the American Chemical Society
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developed a new graphene-nanoparticle hybrid struc-
ture, encapsulated with GO on the surface of positively-
charged silica nanoparticles (SiNP-GO), to enhance the 
differentiation of human neural stem cells (hNSCs). As a 
result, numerous studies have discussed the control and 
acceleration of osteogenic differentiation of hMSCs on 
graphene based hybrid nanomaterials.
As previously mentioned, graphene-based hybrid 
nanomaterials, such as graphene oxide (GO), have chem-
ical, electrical, and mechanical properties favorable for 
tissue engineering applications. In 2011, Nayak et  al. 
[42] reported that a graphene-coated substrate acceler-
ated the osteogenesis of hMSCs. The authors showed 
that the hMSCs, incubated on graphene-coated Si/SiO2 
substrates, showed accelerated differentiation, but the 
presence of graphene did not affect the morphology and 
growth of the cells in normal cell media compared to 
other substrates (PDMS, PET, glass slide).
Kim et al. [78] also demonstrated that graphene-coated 
surfaces are potentially valuable as conducive material 
for protein attachment due to the presence of hydropho-
bic and hydrophilic patches. They produced a graphene-
based hybrid substrate, using a graphene-incorporated 
chitosan substrate (Fig.  7A). The substrates were fabri-
cated after spin-coating rGO and chitosan mixtures (0, 
0.05, 0.5, and 5%) on bare glass, ranging from 0.9, 1.5, 
3.7, to 7.7 nm on average. Figure 7B shows the degree of 
hMSCs osteogenesis for 21 days on TCPS (as control) and 
the 0-5% RGO–chitosan substrata, as analyzed using Aliz-
arin Red S staining, and measured with an ELISA reader.
The result showed that the osteogenic differentiation 
values of the hMSCs on the RGO–chitosan substrata 
were higher than those of the TCPS and chitosan sub-
strate. In addition, Western blot analysis of hMSCs, cul-
tured on 5% RGO–chitosan substrate, chitosan substrate, 
and TCPS, was conducted in the presence of osteocal-
cin (OCN) (Fig. 7C), an osteogenic gene, to confirm the 
improvement in osteogenesis. The results also showed 
that the OCN protein on the graphene–chitosan sub-
strate was up-regulated compared to that on the TCPS 
and chitosan substrata. It was also reported that the 
MMP-cleaved osteopontin (MMP-cleaved OPN) led to a 
considerable increase in cell adhesion. Moreover, the pro-
tein expression of the MMP-cleaved OPN of hMSCs was 
analyzed, and the results indicated that the MMP-cleaved 
OPN on the RGO–chitosan substrate yielded more pro-
tein products than TCPS and chitosan substrate. In spite 
of the small amount of graphene used, these results indi-
cated that the graphene-incorporated chitosan substrate 
could promote the osteogenesis of hMSCs.
Therefore, graphene-incorporated chitosan nanocom-
posites have shown immense potentials in enhancing the 
adhesion and differentiation of the hMSCs. The studies 
above delineated the versatile capability of graphene 
hybrid materials in differentiation of various types of 
stem cells, especially hMSCs. As such, graphene-based 
hybrid nanomaterials can be employed as part of an 
effective strategy in biomedical applications and stem cell 
tissue engineering systems [79].
3.3  Three‑dimensional carbon nanomaterials
Carbon nanomaterials come in forms of graphene sheets, 
ranging from zero-dimensional (0D) to two-dimensional 
(2D), and three-dimensional (3D) graphene structures 
[80]. While graphene is widely recognized for their 
unique physicochemical properties both separately and 
as hybrid carbon-based nanomaterials, the versatility 
of graphene has expanded to its application in three-
dimensional structures. The following section will review 
information on three-dimensional graphene structures, 
such as graphene nano-onions (GNOs), graphene nanor-
ibbons (GONRs), graphene nanoplatelets (GONPs), 3D 
graphene oxide encapsulated gold nanoparticle, and 3D 
graphene foams (GFs) [80–82]. The three-dimensional 
graphene structures are mostly utilized in detection of 
neural stem cell differentiation.
In 2013, Kim et  al. proposed a spectroelectrochemi-
cal method to fabricate 3D graphene oxide encapsulated 
gold nanoparticles. The fabricated 3D GO structure 
was enhanced by combined chemical/electromagnetic 
enhancement of raman signals. In order to account for 
undifferentiated stem cells with high C=C saturation, 
the fabricated structure was merged with SERS, which 
was highly effective in monitoring neural stem cell 
differentiation.
Talukdar et al. on the other hand, reportedly provided 
morphological information on GNOs, GONRs, and 
GONPs with transmission electron microscope (TEM) 
[81]. The diameters of the GNOs were in the range from 
50 to 300 nm, and GNOs came in shapes of onions with 
vacant, multi-walled, and concentric polyhedral struc-
tures. In addition, Talukdar found out that GONRs came 
in shapes of rectangular sheets, and GONPs had disk-like 
morphology.
However, we wish to highlight the promotion of osteo-
genesis by hMSCs using graphene foams (GFs) substrate 
[80]. The GFs were initially grown on a 3D nickel scaf-
fold after which Ni was removed by FeCl3 etching. As 
presented in Fig.  8A, hMSCs attachment was increased 
in the GF substrate, co-localized with collagen, one of the 
ECM proteins known to bind hMSCs, when compared 
to phosphate-buffered saline (PBS). Moreover, the cell 
viability was observed for the hMCS that was cultured in 
3D GFs substrate for over 14 days (Fig. 8B). The results 
showed that most viable cells (green) survived with few 
dead cells (red), indicating that the GFs are capable of 
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supporting the attachment of hMSCs, as well as cell via-
bility. Moreover, the GFs substrate was shown for 7 days 
in comparison to TCPS to have fewer number of cells 
(Fig.  8C) which implies the radical difference in whole 
cell and nuclear morphologies. However, as shown in 
Fig.  8A-C, the hMSCs on the GFs showed long protru-
sions up to 100 mm in length. The authors claim that the 
high porosity of the material resulted in the lower hMSC 
attachment on the GFs than that on the TCPS. However, 
the reduced attachment could be improved by employ-
ing a bioreactor, and through pore architecture/size 
optimization.
Therefore, as demonstrated in the studies above, 
GFs has enough potentials to be utilized as an effective 
substrate to enhance the attachment of hMSCs, maintain 
the cell viability, and stimulate morphological changes 
without extrinsic biochemical inputs.
4  Conclusion
In this study, we highlighted several studies utilizing 
carbon-based nanomaterials for biomedical applications, 
with particular focus on the use of fullerene, CNT, and 
graphene and its derivatives to guide the osteogenesis of 
MSCs.
A number of previous studies have confirmed that car-
bon-based materials and their related materials possess 
the ability to induce hMSC differentiation into specific 
lineages. Specifically, the use of carbon-based materials 
Fig. 7 A Schematic diagram showing the synthesis of graphene‑incorporated chitosan nanocomposite substrata. B Quantification of the degree 
of osteogenesis confirmed by the mineralization as measured by Alizarin Red S staining of hMSCs cultured on the RGO–chitosan substrata, chitosan 
substrata, and TCPS for 21 days. C Western blot analysis of full length OCN expression and expression of MMP‑cleaved OPN in hMSCs cultured on 5% 
RGO–chitosan substrata, chitosan substrata, and TCPS. The reprint of this figure from [78] is permitted by the Royal Society of Chemistry
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in combination with differentiation factors/osteoinduc-
tive agents (e.g. peptides, proteins, growth factors) have 
been reported. These materials were found to act as an 
attracting signal for the osteogenesis of MSCs, as well as 
for bone cells to promote the bone regeneration process. 
Among several carbon-based materials, graphene and 
graphene derivatives have shown great potential for stem 
cell research, due in part to their unique physicochemi-
cal properties such as high surface area, ease of func-
tionalization, and low cytotoxicity. These properties are 
superior to other types of carbon-based materials in term 
of embedding drugs/growth factors and enhancing cell 
adhesion, proliferation, and differentiation of hMSCs into 
osteogenic lineages.
Fig. 8 Protein adsorption, hMSC attachment, and morphological changes on 3D GFs. A Images of bright field (BF), fluorescent (FITC), and merged 
images reveal FITC‑labeled collagen homogeneously adsorbed onto the surface of graphene foams (GFs). B The attachment and viability of FITC‑
labeled hMSCs were supported by GFs over 14 days. C FITC‑labeled hMSCs were cultured in GFs and TCPS control over 7 days. D Quantification 
of FITC‑labeled hMSCs were cultured in GFs and TCPS control over 7 days. E Quantification number of number of whole cell and F aspect ratio. G 
Quantitatively nuclear morphology and H aspect ratio. The re‑print of this figure from [41] is permitted by the Royal Society of Chemistry
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On the other hand, hybrid carbon and three-dimensional 
carbon nanomaterials are examples of modified carbon-
based nanomaterial. Carbon-based materials can be easily 
functionalized with a variety of materials including biomol-
ecules/proteins, nanoparticles, metal structures, and poly-
mers, all of which absorb biomolecules or substances of 
choice in order to induce and control the behavior of stem 
cells. These hybrid materials were also shown to be effec-
tive in enhancement of stem cell growth and differentia-
tion toward specific lineage, including bone cell generation, 
in 2D or 3D environments. Despite the fact that research 
on the use of carbon-based nanomaterials for bone tissue 
engineering is still in its early stages of development, there 
may be a brighter future for its advancement in biomedical 
applications, especially for the stem cell-based regenerative 
therapies, owing to the several advantages of carbon-based 
materials such as low cytotoxicity, biocompatibility and 
ease of functionalization with other types of biological 
components (e.g. DNAs/RNAs, proteins, biomolecules). 
Such technology could be also highly useful in healing vari-
ous incurable disease/disorders, which still cannot be prop-
erly treated using existing medical technology.
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